Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
LAS VEGAS, June 9, 2013 /CNW/ - CardioVascular BioTherapeutics, Inc. (CVBT) announced today that its shareholders have voted by over 60% to amend the bylaws of CVBT, remove specific directors of the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.